{
    "nct_id": "NCT04098744",
    "official_title": "A Phase II Double Blind, Placebo-controlled, Randomized Trial of Artesunate Vaginal Inserts for the Treatment of Patients With Cervical Intraepithelial Neoplasia (CIN2/3)",
    "inclusion_criteria": "* Adult females age ≥ 25 years\n* Capable of informed consent\n* Any HPV genotype detectable by DNA test/HPV genotyping\n* Colposcopically-directed, histologically confirmed tissue diagnosis of cervical high grade squamous intraepithelial lesions (CIN2, CIN3, or CIN2/3)\n* Women of childbearing potential agree to use birth control through week17 of the study.\n* Weight ≥ 50kg\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 25 Years\nMust have maximum age of 100 Years",
    "exclusion_criteria": "* Pregnant and nursing women\n* Active autoimmune disease\n* Taking immunosuppressive medication\n* HIV seropositivity\n* Immunocompromised subjects\n* Evidence of concurrent cervical adenocarcinoma in situ\n* Concurrent malignancy except for nonmelanoma skin lesions, because treatment for other cancers have systemic effects",
    "miscellaneous_criteria": ""
}